Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY(2017)